Drug profile · INN
acetaminophen
ACEPHEN
acetaminophen (ACEPHEN) is a cyclooxygenase inhibitor. Associated with Teva Pharma GmbH. Route of administration: rectal. Current US regulatory status: approved.
Drug details — acetaminophen
- US status
- approved
- Class
- —
- Route
- RECTAL
- Patents
- 20
- Programs
- 140
- Data quality
- 0.89
Quick answer
acetaminophen (ACEPHEN) is a cyclooxygenase inhibitor. Associated with Teva Pharma GmbH. Route of administration: rectal. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Fatty-acid amide hydrolase 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12410474
Methods, kits, and devices for diagnosing, prognosing, and treating psychiatric disorders in a patient
granted -
US 12377036
Melanin hair dye with thickeners
granted -
US 12370267
Inhibition of fibrosis and AF by TGF-beta inhibition in the posterior left atrium (PLA)
granted -
US 12351574
Selective ligands for modulation of GIRK channels
granted -
US 12337019
Vehicles for applying bacteria to skin, scalp, and hair
granted -
US 12331279
Systems for producing cellular immunotherapeutics and methods of use thereof
granted -
WO 2025114603
COMBINAISONS PHARMACEUTIQUES DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT D'INFECTIONS FONGIQUES
granted -
US 12319711
Spherical nucleic acids with tailored and active protein coronae
granted -
US 12291533
Substituted fused pyrimidine compounds and uses thereof
granted -
US 12281310
Use of trinucleotide repeat RNAs to treat cancer
granted -
US 12264344
Protein/oligonucleotide core-shell nanoparticle therapeutics
granted -
US 12258418
Claudin18.2 binding moieties and uses thereof
granted -
US 12252522
Myokines for treating cell proliferative and metabolic diseases and disorders
granted -
US 12252492
Substituted fused pyrrolo-diazepinones and uses thereof
granted -
US 12247063
Cell surface modification by coating with peptide amphiphiles (PAs)
granted -
US 12233081
Hygromycin a compounds and methods of treating spirochete diseases
granted -
US 12233080
Lipotechoic acid for immune modulation
granted -
US 12226444
Compositions comprising peptides comprising variant kinesin light chain 1 and cell-penetrating peptides
granted -
US 12226410
Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6
granted -
US 12214076
Drug delivery vehicles for atherosclerosis nanomedicine
granted
Frequently asked questions
What is acetaminophen?
acetaminophen (ACEPHEN) is a cyclooxygenase inhibitor. Associated with Teva Pharma GmbH. Route of administration: rectal. Current US regulatory status: approved.
What is the brand name for acetaminophen?
ACEPHEN is a marketed brand name for acetaminophen. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of acetaminophen?
acetaminophen has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.